Accelerated Development of Appropriate Patient Therapies
a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes
Work package 1 has focused on evidence generation (in a MAPPs context) throughout the product life-cycle. Earlier work has reviewed IMI and non-IMI projects that might further support different stakeholders in developing and/or implementing the MAPPs approach.
D1.02 aimed to analyse and monitor IMI and non IMI project outputs, and to perform a gap analysis of the wealth of evidence generation in the context of MAPPs. In other words, tools and methods developed by IMI and other EU projects, which could benefit MAPPs have to be identified. To this effect, a two-phase process was identified.
